Navigation Links
Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
Date:2/12/2008

bavituximab in combination with chemotherapy. The first bavituximab breast cancer trial is now underway and the two other trials are expected to begin soon. Bavituximab is in clinical trials in the U.S. in patients with advanced solid tumors and in patients co-infected with HCV and HIV.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to, the risk that the company will experience delays or difficulties in enrolling patients in the study, the risk that the standard docetaxel response rate will not be improved as a result of the combination therapy, and the risk that the results from this trial will not be consistent with the results of prior trials or preclinical studies. It is important to note that the company's actual results could differ materially from th
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
2. Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
3. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
4. Peregrine Pharmaceuticals to Announce Second Quarter FY 2008 Financial Results
5. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
6. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
7. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
8. Access Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
9. XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
10. Koronis Pharmaceuticals Appoints David Drajeske Director of Business Development
11. Onyx Pharmaceuticals to Present at BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2015)...  Health eCareers, the healthcare industry,s online career ... seekers looking for the flexibility of short-term assignments ... online tool dedicated exclusively to temporary and shift ... enables employers to quickly find and hire experienced ... and other temporary positions, eliminating the time and ...
(Date:5/20/2015)... YORK , May 20, 2015  Marc ... a leadership gift of $100 million from The ... create a new laboratory building that will be ... extension. The Marie-Josée and Henry R. Kravis Research ... the FDR Drive, spanning approximately three city blocks ...
(Date:5/20/2015)... , May 20, 2015  Cypher Genomics, Inc., ... collaboration with Celgene Corporation to apply Cypher,s Coral ... that associate with patient response to innovative medicines. ... to help accelerate patient access to the right ... clinical research and development and potentially inform new ...
(Date:5/20/2015)... , May 19, 2015 Research and Markets ... addition of the "Bone Morphogenetic Proteins Market ... Trauma, Reconstructive and Oral - Maxillofacial) - Global ... 2014 - 2022" report to their offering. ... is studied based on the types of recombinant ...
Breaking Biology Technology:Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 3The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 2The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 3The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 4Cypher Genomics Collaborates with Celgene Corporation to Identify Novel Genomic Biomarkers 2Global Bone Morphogenetic Proteins Market Industry Analysis 2014 - 2022 2
... September 29, 2010 ... ... var shortURL ... longUrl, so we need to grab the first one. for (var r in data.results) { first_result = ...
... that glow like fireflies could someday help doctors heal damaged ... University of Central Florida lab, Steven Ebert engineered stem cells ... stem cells glow brighter and brighter as they develop into ... the stem cells are working. Researchers are keenly interested ...
... For his significant and global contributions to clean water ... and his commitment to invention and the pursuit of ... Engineering degree from Stevens Institute of Technology at the ... Dr. Meng, a professor in the Charles V. Schaefer, ...
Cached Biology Technology:Crescendo Biologics Announces First 'Triple Knockout' Mouse 2Crescendo Biologics Announces First 'Triple Knockout' Mouse 3Crescendo Biologics Announces First 'Triple Knockout' Mouse 4Crescendo Biologics Announces First 'Triple Knockout' Mouse 5Crescendo Biologics Announces First 'Triple Knockout' Mouse 6Crescendo Biologics Announces First 'Triple Knockout' Mouse 7Crescendo Biologics Announces First 'Triple Knockout' Mouse 8Xiaoguang Meng receives honorary master of engineering from Stevens 2Xiaoguang Meng receives honorary master of engineering from Stevens 3
(Date:5/10/2015)... GOTHENBURG, Sweden , May 11, 2015 ... touch fingerprint sensors FPC1025 and FPC1155 from the distributor World ... one of FPC,s distributors in Asia . ... the sensors will be used by smartphone manufacturers in ... is included in the communicated revenue guidance of + 1 000 ...
(Date:5/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market, reminds investors and media that  Mr. ...  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of nine ... Global Fraud: Where is the Trust in Cyberspace? ...
(Date:4/21/2015)... , April 21, 2015 ... evolving government policies are boosting access control systems market ... According to a recently published report by TechSci ... 2020 ", the access control systems market in ... USD1.2 billion by 2020.The access control systems market in ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3
... WASHINGTON, Sept. 26 2007 -- Consuming large amounts of ... used painkillers in the United States, could potentially cause ... in the Oct. 15 print issue of ACS Chemical ... could occur not only from drinking caffeinated beverages while ...
... said today that the discovery of 11 new animal and ... the importance of conservation efforts in the ancient tropical forests ... tropical forests of a region known as Vietnams Green Corridor, ... well as three other plants new to science and exclusive ...
... sensing the magnetic reference direction, have recently been found ... PNAS, 2004). Furthermore, studies investigating what parts of a ... their magnetic compass showed that the cryptochrome-containing neurons in ... et al., PNAS, 2005; Liedvogel et al., EJN, 2007) ...
Cached Biology News:Mixing large doses of both acetaminophen painkiller and caffeine may increase risk of liver damage 2New animal and plant species found in Vietnam 2
... Process Control at its Best: DASGIPs ... Monitoring, Online Changes & comprehensive documentation ... of parameters auch as pH, dissolved ... accessible and changeable online. Profiles, e.g. ...
... synthetic peptide whose sequences are derived from mouse resistin protein. ... - S - M - P - L - C - ... - D - K - K - I - K - ... used for neutralization and control experiments with the polyclonal antibody that ...
... peptide microarrays designed for quantitative assays ... and built on the flexible and ... of customer specified sequences can be ... provide assistance with custom sequence design. ...
... for OPA1-01009, OPEP-01009 is a 16 amino acid (amino acids ... factor (DFF). The sequence of this peptide is (amino ... - S - V - K - L - R ... - R - K(18). This peptide may be ...
Biology Products: